Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02924285Phase 3Completed
Phase 3, randomised, open-label trial (2 arms), sponsored by Leipzig University. Primary endpoint: Verification of superiority of catheter ablation over amiodarone for treatment of PVCs in patients with structural heart disease at 6 weeks. Started Nov 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02924285.